Stephanie J. Schrag
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Stephanie J. Schrag has a total of 143 co-authors. Here are the top co-authors by number of shared publications:
Anne Schuchat
6 shared publicationsAllen S. Craig
3 shared publicationsElizabeth R. Zell
3 shared publicationsLee H. Harrison
3 shared publicationsBernard Beall
Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention,1 Department of International Health, Rollins School of Public Health, and Division of Infectious Diseases, School of Medicine, Emory University, Atlanta, Georgia,2 Tennessee Department of Health, Nashville, Tennessee,3 Department of Pathology, University of Texas Health Science Center at San Antonio, San Antonio, Texas4
2 shared publicationsCynthia G. Whitney
Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention,1 Department of International Health, Rollins School of Public Health, and Division of Infectious Diseases, School of Medicine, Emory University, Atlanta, Georgia,2 Tennessee Department of Health, Nashville, Tennessee,3 Department of Pathology, University of Texas Health Science Center at San Antonio, San Antonio, Texas4
2 shared publications
Latest Publications
- 3 November 2021
- Published by Elsevier in The Lancet
- Vol. 399 (10320) , 152-160
Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data
- 3 November 2021
- Published by Elsevier in The Lancet
- Vol. 399 (10320) , 152-160
Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data
- Open Access
- 16 November 2020
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 20 (1) , 1-9
Features of Streptococcus agalactiae strains recovered from pregnant women and newborns attending different hospitals in Ethiopia
Background: Streptococcus agalactiae(Group B Streptococcus, GBS) serotypes, sequence types, and antimicrobial resistance profile vary across different geographic locations affecting disease patterns in newborns. These differences are important considerations for vaccine development efforts and data from large countries in Africa is limited. The aim of this study was to determine serotypes and genotypes of GBS isolates from pregnant women and their newborns in Ethiopia.Methods: A hospital based cross-sectional study was conducted at three hospitals in Ethiopia from June 2014 to September 2015. Out of 225 GBS isolates, 121 GBS were recovered, confirmed and characterized at CDC’s Streptococcus Laboratory using conventional microbiology methods and whole genome sequencing.Results: Of the 121 isolates, 87 were from rectovaginal samples of pregnant women, 32 from different body parts of their newborns and 2 from blood of newborns with suspected sepsis. There were 25 mother-infant pairs and 24 pairs had concordant strains. The most prevalent serotypes among mothers and/or their babies were II, Ia and V (41.5, 20.6, 19.5 and 40.6%, 25 and 15.6%, respectively). Multilocus sequence typing (MLST) on 83 isolates showed ST10 (24; 28.9%) and ST2 (12; 14.5%) as most predominant sequence types. All GBS strains were susceptible to penicillin, cefotaxime and vancomycin, which correlated to the presence of wildtype PBP2x types and the lack of known vancomycin-resistance genes. Tetracycline resistance was high (73; 88%, associated primarily withtetM, but alsotetOandtetL). Five isolates (6%) were resistant to erythromycin and clindamycin and 3 isolates were fluoroquinolone-resistant, containing associated mutations ingyrAandparCgenes. All isolates were positive for one of four homologous Alpha/Rib family determinants and 1–2 of the three main pilus types.Conclusions: Predominant serotypes were II, Ia, and V. A limited number of clonal types were identified with two STs accounting for about half of the isolates. All strains collected in this study were susceptible to beta-lactam antibiotics and vancomycin. Typical of most GBS, these isolates were positive for single alpha-like family protein, serine-rich repeat gene, as well as 1–2 pilus determinants.
- 16 November 2020
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 20 (1) , 1-9
Open AccessFeatures of Streptococcus agalactiae strains recovered from pregnant women and newborns attending different hospitals in Ethiopia
Background: Streptococcus agalactiae(Group B Streptococcus, GBS) serotypes, sequence types, and antimicrobial resistance profile vary across different geographic locations affecting disease patterns in newborns. These differences are important considerations for vaccine development efforts and data from large countries in Africa is limited. The aim of this study was to determine serotypes and genotypes of GBS isolates from pregnant women and their newborns in Ethiopia.Methods: A hospital based cross-sectional study was conducted at three hospitals in Ethiopia from June 2014 to September 2015. Out of 225 GBS isolates, 121 GBS were recovered, confirmed and characterized at CDC’s Streptococcus Laboratory using conventional microbiology methods and whole genome sequencing.Results: Of the 121 isolates, 87 were from rectovaginal samples of pregnant women, 32 from different body parts of their newborns and 2 from blood of newborns with suspected sepsis. There were 25 mother-infant pairs and 24 pairs had concordant strains. The most prevalent serotypes among mothers and/or their babies were II, Ia and V (41.5, 20.6, 19.5 and 40.6%, 25 and 15.6%, respectively). Multilocus sequence typing (MLST) on 83 isolates showed ST10 (24; 28.9%) and ST2 (12; 14.5%) as most predominant sequence types. All GBS strains were susceptible to penicillin, cefotaxime and vancomycin, which correlated to the presence of wildtype PBP2x types and the lack of known vancomycin-resistance genes. Tetracycline resistance was high (73; 88%, associated primarily withtetM, but alsotetOandtetL). Five isolates (6%) were resistant to erythromycin and clindamycin and 3 isolates were fluoroquinolone-resistant, containing associated mutations ingyrAandparCgenes. All isolates were positive for one of four homologous Alpha/Rib family determinants and 1–2 of the three main pilus types.Conclusions: Predominant serotypes were II, Ia, and V. A limited number of clonal types were identified with two STs accounting for about half of the isolates. All strains collected in this study were susceptible to beta-lactam antibiotics and vancomycin. Typical of most GBS, these isolates were positive for single alpha-like family protein, serine-rich repeat gene, as well as 1–2 pilus determinants.
- 1 June 2019
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 94 (2) , 157-159
Antenatal and intrapartum nucleic acid amplification test use for group B Streptococcus screening—United States, 2016
- 1 June 2019
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 94 (2) , 157-159
Antenatal and intrapartum nucleic acid amplification test use for group B Streptococcus screening—United States, 2016
- 1 January 2019
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 19 (1) , 8-10
Group B streptococcal disease: unmet needs in high-income countries
- 1 January 2019
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 19 (1) , 8-10
Group B streptococcal disease: unmet needs in high-income countries
- 18 June 2009
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 360 (25) , 2626-2636
Evaluation of Universal Antenatal Screening for Group B Streptococcus
Group B streptococcal disease is one of the most common infections in the first week after birth. In 2002, national guidelines recommended universal late antenatal screening of pregnant women for colonization with group B streptococcus to identify candidates for intrapartum chemoprophylaxis.
- 18 June 2009
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 360 (25) , 2626-2636
Evaluation of Universal Antenatal Screening for Group B Streptococcus
Group B streptococcal disease is one of the most common infections in the first week after birth. In 2002, national guidelines recommended universal late antenatal screening of pregnant women for colonization with group B streptococcus to identify candidates for intrapartum chemoprophylaxis.
- Open Access
- 15 October 2004
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 39 (8) , 1136-1138
The Past and Future of Perinatal Group B Streptococcal Disease Prevention
Over the past 15 years, the story of perinatal group B streptococcal (GBS) disease prevention has been one of continued challenges and surprising success. The d
- 15 October 2004
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 39 (8) , 1136-1138
Open AccessThe Past and Future of Perinatal Group B Streptococcal Disease Prevention
Over the past 15 years, the story of perinatal group B streptococcal (GBS) disease prevention has been one of continued challenges and surprising success. The d
- 1 August 2004
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 48 (8) , 3016-23
Emergence of Streptococcus pneumoniae with Very-High-Level Resistance to Penicillin
Penicillin resistance threatens the treatment of pneumococcal infections. We used sentinel hospital surveillance (1978 to 2001) and population-based surveillance (1995 to 2001) in seven states in the Active Bacterial Core surveillance of the Emerging Infections Program Network to document the emergence in the United States of invasive pneumococcal isolates with very-high-level penicillin resistance (MIC ≥ 8 μg/ml). Very-high-level penicillin resistance was first detected in 1995 in multiple pneumococcal serotypes in three regions of the United States. The prevalence increased from 0.56% (14 of 2,507) of isolates in 1995 to 0.87% in 2001 ( P = 0.03), with peaks in 1996 and 2000 associated with epidemics in Georgia and Maryland. For a majority of the strains the MICs of amoxicillin (91%), cefuroxime (100%), and cefotaxime (68%), were ≥8 μg/ml and all were resistant to at least one other drug class. Pneumonia (50%) and bacteremia (36%) were the most common clinical presentations. Factors associated with very highly resistant infections included residence in Tennessee, age of 23F -4 and 35% were related to England 14- 9. After the introduction of the pneumococcal conjugate vaccine, the incidence of highly penicillin resistant infections decreased by 50% among children <5 years of age. The emergence, clonality, and association of very-high-level penicillin resistance with multiple drug resistance requires further monitoring and highlights the need for novel agents active against the pneumococcus.
- 1 August 2004
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 48 (8) , 3016-23
Emergence of Streptococcus pneumoniae with Very-High-Level Resistance to Penicillin
Penicillin resistance threatens the treatment of pneumococcal infections. We used sentinel hospital surveillance (1978 to 2001) and population-based surveillance (1995 to 2001) in seven states in the Active Bacterial Core surveillance of the Emerging Infections Program Network to document the emergence in the United States of invasive pneumococcal isolates with very-high-level penicillin resistance (MIC ≥ 8 μg/ml). Very-high-level penicillin resistance was first detected in 1995 in multiple pneumococcal serotypes in three regions of the United States. The prevalence increased from 0.56% (14 of 2,507) of isolates in 1995 to 0.87% in 2001 ( P = 0.03), with peaks in 1996 and 2000 associated with epidemics in Georgia and Maryland. For a majority of the strains the MICs of amoxicillin (91%), cefuroxime (100%), and cefotaxime (68%), were ≥8 μg/ml and all were resistant to at least one other drug class. Pneumonia (50%) and bacteremia (36%) were the most common clinical presentations. Factors associated with very highly resistant infections included residence in Tennessee, age of 23F -4 and 35% were related to England 14- 9. After the introduction of the pneumococcal conjugate vaccine, the incidence of highly penicillin resistant infections decreased by 50% among children <5 years of age. The emergence, clonality, and association of very-high-level penicillin resistance with multiple drug resistance requires further monitoring and highlights the need for novel agents active against the pneumococcus.
- Open Access
- 16 July 2004
- Published by Wiley in Infectious Diseases in Obstetrics and Gynecology
- Vol. 13 (1) , 5-10
Opportunities to Reduce Overuse of Antibiotics for Perinatal Group BStreptococcal Disease Prevention and Management of Preterm Premature Rupture of Membranes
Objective: To identify opportunities to reduce overuse of antibiotics for prevention of perinatal group B streptococcal (GBS) disease and management of preterm premature rupture of membranes (pPROM).Methods: An anonymous written questionnaire was sent to each of 1031 Fellows of the American College of Obstetricians and Gynecologists, and the responses were subjected to statistical analysis.Results: Among those of the 404 respondents who saw obstetric patients in 2001, most (84%) screened for GBS colonization, and 22% of these prescribed prenatal antibiotics to try to eradicate GBS colonization. Of the 382 respondents (95%) who prescribed antibiotics for pPROM, 36% continued antibiotics for more than 7 days despite negative results from GBS cultures collected before initiation of treatment. Having more years of clinical experience (adjusted odds ratio (OR) 3.0, 95% confidence interval (CI) 1.5 to 6.2), working in a non‐academic setting (adjusted OR 2.7, 95% CI 1.0 to 6.9), and prescribing antibiotics prenatally for GBS colonization (adjusted OR 2.0, 95% CI 1.1 to 3.4) were associated with prescribing prolonged antibiotics for pPROM.Conclusion: Prenatal antibiotic treatment for GBS colonization and prolonged antibiotic treatment for pPROM contribute to overuse of antibiotics in obstetrics.
- 16 July 2004
- Published by Wiley in Infectious Diseases in Obstetrics and Gynecology
- Vol. 13 (1) , 5-10
Open AccessOpportunities to Reduce Overuse of Antibiotics for Perinatal Group BStreptococcal Disease Prevention and Management of Preterm Premature Rupture of Membranes
Objective: To identify opportunities to reduce overuse of antibiotics for prevention of perinatal group B streptococcal (GBS) disease and management of preterm premature rupture of membranes (pPROM).Methods: An anonymous written questionnaire was sent to each of 1031 Fellows of the American College of Obstetricians and Gynecologists, and the responses were subjected to statistical analysis.Results: Among those of the 404 respondents who saw obstetric patients in 2001, most (84%) screened for GBS colonization, and 22% of these prescribed prenatal antibiotics to try to eradicate GBS colonization. Of the 382 respondents (95%) who prescribed antibiotics for pPROM, 36% continued antibiotics for more than 7 days despite negative results from GBS cultures collected before initiation of treatment. Having more years of clinical experience (adjusted odds ratio (OR) 3.0, 95% confidence interval (CI) 1.5 to 6.2), working in a non‐academic setting (adjusted OR 2.7, 95% CI 1.0 to 6.9), and prescribing antibiotics prenatally for GBS colonization (adjusted OR 2.0, 95% CI 1.1 to 3.4) were associated with prescribing prolonged antibiotics for pPROM.Conclusion: Prenatal antibiotic treatment for GBS colonization and prolonged antibiotic treatment for pPROM contribute to overuse of antibiotics in obstetrics.